W. Michael Flanagan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 8 hours ago
W. Michael Flanagan has an estimated net worth of at least $13.6 million*, as of Feb. 5, 2025. They own 91,975 shares of RNA stock. They have sold 255,543 shares of RNA stock since 2021, for an estimated $10.4 million.
W. Michael Flanagan $RNA SEC Form 4 Insider Trading
W. Michael Flanagan has filed a total of 12 insider trades in $RNA since 2021. Their most recent trade was a sale of 1,812 shares, made on Jan 21, 2025. Their largest trade was a sale of 62,500 shares, made on Oct 01, 2024. We estimate that they now own 91,975 shares of $RNA, worth an estimated $3.1 million.
Insider Trading at $RNA
There have been a total of 97 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.1 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 5,875 shares reported by Kathleen P. Gallagher (Chief Program Officer), made on Feb 03, 2025.
History of Insider Stock Trades by W. Michael Flanagan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 1,812 | Jan 21, 2025 | Jan. 23, 2025, 9:12 p.m. |
|
RNA
|
Sale | 3,860 | Jan 21, 2025 | Jan. 23, 2025, 9:12 p.m. |
|
RNA
|
Sale | 12,742 | Dec 18, 2024 | Dec. 19, 2024, 7:17 p.m. |
|
RNA
|
Sale | 24,000 | Dec 11, 2024 | Dec. 13, 2024, 7:08 p.m. |
|
RNA
|
Sale | 62,500 | Oct 01, 2024 | Oct. 3, 2024, 4:09 p.m. |
|
RNA
|
Sale | 11,847 | Sep 23, 2024 | Sept. 23, 2024, 9:03 p.m. |
|
RNA
|
Sale | 13,153 | Sep 23, 2024 | Sept. 23, 2024, 9:03 p.m. |
|
RNA
|
Sale | 62,500 | Sep 11, 2024 | Sept. 13, 2024, 4:25 p.m. |
|
RNA
|
Sale | 34,000 | Sep 11, 2024 | Sept. 13, 2024, 4:25 p.m. |
|
RNA
|
Sale | 14,894 | Sep 11, 2024 | Sept. 13, 2024, 4:25 p.m. |
|
RNA
|
Sale | 10,106 | Jun 18, 2024 | June 20, 2024, 6:47 p.m. |
|
RNA
|
Sale | 4,129 | Jan 22, 2024 | Jan. 23, 2024, 4:12 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Arthur A Levin, Chief Scientific Officer
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
W. Michael Flanagan, CSTO
-
Kathleen P. Gallagher, Chief Program Officer
-
Steven George Hughes, Chief Medical Officer
-
W. Michael Flanagan, Chief Scientific Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.